name: tocilizumab
description: targets soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R). Previously used for rheumatoid arthritis, systemic juvenile idiopathic arthritis, and CAR T cell induced severe or life threatening cytokine release syndrome in conjunction with protease inhibitors
therapeutic:
  - antibody
links:
  wikipedia: Tocilizumab
  drugbank: DB06273
target:
  - host immune response
mechanism: Targets soluble and membrane-bound IL-6 receptors to decrease immune and inflammatory responses
protein:
  - IL6R
